Kremlin Politics Are Bad for Russia’s Health
(Bloomberg Opinion) -- “I don't even know what is going on,” President Vladimir Putin complained to ministers last month, exasperated that even “well-educated people, with higher degrees” continue to refuse Russia's Covid-19 vaccination. “Why wait for the disease and its severe consequences?”
For an administration obsessed with demographics, scientific reputation and global status, the blow has been devastating. With far too few citizens vaccinated, Russia suffered the deadliest September since World War II, and daily cases have kept rising. The Kremlin has been forced to impose a “non-working” week until Nov. 7, with Moscow introducing a partial lockdown. Not for the first time since Putin came to power just over two decades ago, promising to reverse a demographic decline, political imperatives have hampered public health.
Russia was first to approve a coronavirus shot in 2020, to great fanfare, and has had one of the longest inoculation campaigns globally. Real world data suggest the shot is effective. Yet only roughly a third of citizens are fully vaccinated, a level far below Europe and the United States; the number of Russians who say they are not ready to get the shot has decreased, but is still 45%. After slowing over recent months, the rate of vaccination only began to speed up during October's surge. Other parts of the world are also seeing cases rise as winter sets in, but inoculation has limited the damage. Meanwhile, Russia's daily deaths have been at their highest level yet.
What's behind the crisis? At the most basic level, competing Kremlin priorities have condemned the country to fight the virus for far longer than many of its rivals. Strong fossil fuel prices will blunt some of the economic consequences for Russia, but the impact on its consumers and society will linger. Between October 2020 and September 2021, excluding the effects of migration, the population declined by close to a million people, according to independent demographer Alexei Raksha.
All governments find it hard to change course. But authoritarian states in particular have found themselves pinned down. China remains trapped in its efforts to keep Covid-19 cases at zero, imposing draconian quarantines and accepting heavy social and economic costs to prolong a state that will prove impossible to maintain. More than 30,000 people were locked in and tested at Shanghai Disneyland on Sunday, after one visitor a day earlier triggered a contact tracing drive. At least that harsh approach has saved lives. The same cannot be said of Russia.
Under Putin — for whom population is a proxy for might — there have been improvements to public health, even if spending remains muted in absolute terms and as a percentage of gross domestic product. The number of hospitals was rationalized, rebalancing the skewed Soviet-era distribution of resources; the proportion requiring major repairs shrank from 27% in 2000 to just under 17% in 2018. Much of the benefit accrued to Moscow and other big cities, but it's still significant. Campaigns against alcohol abuse and tobacco helped to improve dismal male life expectancy. So too did a recovering economy. And yet, the Kremlin's contradictions have kept a lid on demographic progress.
Consider efforts to encourage births. Improving conditions for women at home and at work, plus quality childcare, have made a difference elsewhere. In Russia, however, where Putin has positioned himself as a protector of conservative and family values, domestic violence was partially decriminalized in 2017 and abortion has been restricted. He has focused his efforts on welfare payments like “maternity capital.” The birth rate is shrinking.
Or consider efforts to tackle HIV/AIDS, hampered by the same social conservatism, the increased influence of the Russian Orthodox Church, efforts to marginalize the LGBTQ community and crackdowns on non-governmental organizations. Adjusted for population, 2020 numbers suggest a rate of infection ten times higher than that in European Union countries. Most cases come from heterosexual contact.
A similarly toxic political combination has played out with Covid-19.
For one, although Russia's system is one that centralizes power and resources, Putin devolved pandemic responsibility to the regions. The result has been dramatically uneven. Judy Twigg, a professor at Virginia Commonwealth University who studies Russian politics and health, points out that regions with stronger leaders did better as they were more willing — and able — to test out their own ideas for Covid-19 prevention and vaccination. In Belgorod, a region to the south of Moscow, a strategy of paying medical workers to boost jabs yielded much higher vaccination rates, and fewer hospitalizations.
Then there's the difficulty of conveying urgency, in a system that does not privilege bad news. Moscow initially sought to minimize the virus, lifted early lockdowns prematurely, boasted about its success in avoiding closures. Putin is almost never pictured in a mask. Official rhetoric is changing under the weight of circumstances, but this existing narrative has made it far harder to switch to demanding strict lockdowns or national vaccine mandates. As the toughest restrictions in months came in over the past few days, the unintended consequence was a surge in foreign holidays.
Most hazardous of all to Russia's pandemic response, though, has been the Kremlin's toxic nationalist propaganda. Officials bet they could separate broadsides aimed at the West and the constant denigration of Western vaccines at home from domestic cheerleading. Instead, this approach just amplified existing hesitancy, something the Kremlin has also done little to reverse. Putin took his vaccination behind closed doors. And he absurdly claimed last month that foreigners were coming from Europe to get the Sputnik jab “because it is more reliable” and then buying false vaccine certificates. Official death figures, meanwhile, have lingered around improbably similar numbers — for example before the September legislative election.
All of this leaves Russia caught in a catch-22 of its own making: Unable to bring in Western vaccines, unable to impose mandates at a national level, unwilling to provide the data required for its vaccine to be approved in the European Union, unable to rebuild popular trust.
Not unlike China, Russia must hope that the pandemic ebbs before more challenging political decisions are required.
This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.
Clara Ferreira Marques is a Bloomberg Opinion columnist covering commodities and environmental, social and governance issues. Previously, she was an associate editor for Reuters Breakingviews, and editor and correspondent for Reuters in Singapore, India, the U.K., Italy and Russia.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.